Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Integrating value assessment into discussions about the price of cancer drugs.

Literature DB >> 23036668

Integrating value assessment into discussions about the price of cancer drugs.

Craig Bunnell.

Abstract

Entities: Disease

Mesh：

Substances：
Antineoplastic Agents

Year: 2012 PMID： 23036668 PMCID： PMC3497837 DOI： 10.1016/j.mayocp.2012.08.009

Source DB: PubMed Journal: Mayo Clin Proc ISSN： 0025-6196 Impact factor: 7.616

Keyword Cloud
References

× No keyword cloud information.

10 in total

Review 1. Cost of cancer care: issues and implications.

Authors: Neal J Meropol; Kevin A Schulman
Journal: J Clin Oncol Date: 2007-01-10 Impact factor: 44.544

Review 2. Economics of new oncology drug development.

Authors: Joseph A DiMasi; Henry G Grabowski
Journal: J Clin Oncol Date: 2007-01-10 Impact factor: 44.544

3. Estimating the cost of new drug development: is it really 802 million dollars?

Authors: Christopher P Adams; Van V Brantner
Journal: Health Aff (Millwood) Date: 2006 Mar-Apr Impact factor: 6.301

4. Medical bankruptcy in the United States, 2007: results of a national study.

Authors: David U Himmelstein; Deborah Thorne; Elizabeth Warren; Steffie Woolhandler
Journal: Am J Med Date: 2009-06-06 Impact factor: 4.965

5. Pathways, outcomes, and costs in colon cancer: retrospective evaluations in two distinct databases.

Authors: J Russell Hoverman; Thomas H Cartwright; Debra A Patt; Janet L Espirito; Matthew P Clayton; Jody S Garey; Terrance J Kopp; Michael Kolodziej; Marcus A Neubauer; Kathryn Fitch; Bruce Pyenson; Roy A Beveridge
Journal: J Oncol Pract Date: 2011-05 Impact factor: 3.840

Integrating value assessment into discussions about the price of cancer drugs.

Review 1. Cost of cancer care: issues and implications.

Review 2. Economics of new oncology drug development.

3. Estimating the cost of new drug development: is it really 802 million dollars?

4. Medical bankruptcy in the United States, 2007: results of a national study.

5. Pathways, outcomes, and costs in colon cancer: retrospective evaluations in two distinct databases.

6. Ten common questions (and their answers) about off-label drug use.

7. The high cost of cancer drugs and what we can do about it.

Review 8. European perspective on the costs and cost-effectiveness of cancer therapies.

9. Uncertainty in assessing value of oncology treatments.

10. American Society of Clinical Oncology guidance statement: the cost of cancer care.